Skip to main content

Table 1 Patient characteristics at initiation of HD (n = 166)

From: Lower Hb at the initiation of dialysis does not adversely affect 1-year mortality rate

Clinical findings
 Age (years) 61.5 ± 14.3(30~89)
 Gender (male/female) 110/56
 Systolic/diastolic blood pressure (mmHg) 147 ± 21/76 ± 16
 BW (kg; mean ± SD) 62.6 ± 15.7
 Method of HD initiation (AVF/catheter) 125/41
Primary disease of ESKD
 Diabetic nephropathy 87 (49%)
 Chronic glomerulonephritis 13 (8%)
 Nephrosclerosis 41 (25%)
 Polycystic kidney disease 4 (2.4%)
 Others 21 (12.7%)
Laboratory findings
 Hb (g/dL) 8.56 ± 1.3
 Fe/TIBC (μg/dL) 61 ± 31/212 ± 44
 Ferritin (ng/dL) 305 ± 315
 Serum albumin (g/dL) 3.0 ± 0.6
 BUN/creatinine (mg/dL) 103 ± 33/11.1 ± 4.3
 eGFR (mL/m/1.73m2) 4.5 ± 1.8
 K (mEq/L) 4.7 ± 1.0
 Ca/P (mg/dL) 8.5 ± 1.1/7.6 ± 2.1
 Intact PTH(pg/mL) 186 ± 107
 B-type natriuretic peptide (BNP) (ng/mL) 954 ± 2136 (4~18258)
 Cardiothoracic rate (CTR) (%) 54.8 ± 6.0
 ESA treatment 129 (78%) epoetin beta pegol:89 darbepoetin:40
 ESA dosage (U/week; converted in Epo dosage) 4871 ± 3259
 Erythropoietin resistance index(U/week/Hb (g/dL) × BW (kg)) 9.95 ± 7.36
 Fe treatment 46 (28%)